Update on the PrEP Impact Trial
Implementation of the PrEP Impact trial has been a huge success with over 10,000 participants already enrolled in this important HIV prevention measure.
But, the speed of recruitment and demand for PrEP has significantly exceeded initial expert predictions and the trial researchers now consider that more places should be made available. They argue that recruitment needs to reach a “steady state’ in order to ensure the trial can robustly and scientifically inform the design and rollout of a full national programme in partnership with local authorities. They have also said that the increase will be important for addressing emerging questions from the trial about the need for PrEP amongst women and other groups.
As a result, an official request has been made by the researchers to increase the number of participants to the end of the trial in 2020 from 13,000 to up to 26,000.
NHS England is supportive of the researchers’ proposal and will play its part by committing to fund additional places in line with existing trial funding arrangements.
Implementation of the detailed proposal submitted by the researchers will be considered later this month by the Trial Oversight Board, which includes representatives from Public Health England, local authorities and community groups, alongside NHS England.
John Stewart, Director of Specialised Commissioning at NHS England said: “Through the PrEP trial, over 10,000 people are already receiving access to this important HIV prevention measure. The trial researchers have submitted a case for increasing trial places and NHS England will play its part in delivering on this recommendation by committing to fund additional places in line with existing funding arrangements. This will help ensure the learning from the trial is robust enough to fully inform the planning of a national PrEP programme in partnership with local authorities for the future, as well as protecting more people from HIV right now”.
It will continue to be for individual local authorities to decide how many additional places they wish to take up and to give the green light to clinics to expand recruitment.
For more information on the PrEP Impact trial and participating clinics visit the trial website: www.prepimpacttrial.org.uk.
Latest News from
More convenient cancer screening services must be rolled out to boost uptake, says Professor Sir Mike Richards24/05/2019 15:10:00
The NHS should roll out online booking, out of hours appointments and text reminders to boost the uptake of breast, cervical and other screening services, leading expert Professor Sir Mike Richards said today.
NHS invests £5 million to improve care for people with a learning disability21/05/2019 15:15:00
The NHS has today announced that an additional £5 million will fund reviews to improve care for people with a learning disability and committed to renewed national action to tackle serious conditions.
National Heroes Service: GPs told ‘our veterans need you’20/05/2019 14:15:00
NHS chiefs have urged family doctors to enlist in a scheme improving care for thousands of armed forces veterans and their families.
NHS England to fund first ever treatment for children with rare muscle-wasting condition16/05/2019 09:15:00
NHS England will provide a promising new treatment which can prolong the lives of children with a rare genetic condition after negotiating a deal with the manufacturer.
NHS funds tech to protect prostate cancer patients during radiation treatment14/05/2019 09:15:00
An innovation that can reduce the side-effects of radiotherapy for prostate cancer patients by over 70 per cent will be rolled out across the NHS, as part of the Long Term Plan to put cutting-edge treatments at the heart of people’s care.
Army of NHS experts brought in to care homes to tackle over-medication13/05/2019 09:15:00
An army of experts have been recruited by NHS England to help prevent care home residents being given too many medicines as part of a package of measures to improve older people’s health and care in the NHS Long Term Plan.
NHS England strikes deal to make innovative Multiple Sclerosis drug available, paving the way for NICE recommendation09/05/2019 15:47:00
Patients with Multiple Sclerosis (MS) will have routine access to a drug that can slow disability under a deal struck between NHS England and the manufacturer Roche, paving the way for its approval by NICE.
NHS England funds £2million to boost system-wide leadership development09/05/2019 09:15:00
NHS England has funded a £2million programme to help 23 areas kick-start or boost leadership development activities to support and inspire workforce in health systems across England from GPs, consultants and therapists to nurses, social workers and managers.